Toxicity of phorbol esters for human epithelial cells expressing a mutant ras oncogene

Related Experiment Video

Updated: Nov 8, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

T Dawson1, J Bond, N Eccles

  • 1Department of Pathology, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom.

Molecular Carcinogenesis
|January 1, 1993
PubMed

Insights

Mutant Ras expression enhances sensitivity to phorbol ester toxicity in thyroid cells. This finding supports the development of phorbol ester analogues as anticancer drugs.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Phorbol esters show potential as anticancer agents, but their toxicity mechanisms remain unclear.
  • Conflicting cell line responses complicate the interpretation of phorbol ester toxicity.
  • Previous studies indicated mutant p21ras confers sensitivity to phorbol esters in primary thyroid cells.

Purpose of the Study:

  • To investigate the role of mutant Ras in phorbol ester-induced toxicity using an inducible system.
  • To determine if growth stimulation by mutant Ras is responsible for enhanced phorbol ester sensitivity.
  • To assess the specificity of this phenomenon for biologically active phorbol esters and related compounds.

Main Methods:

  • Utilized a thyroid cell line with an inducible mutant Ras gene.
  • Administered a panel of phorbol esters and bryostatin to assess toxicity.
  • Evaluated cell responses to determine the mechanism of phorbol ester toxicity.

Main Results:

  • Mutant Ras expression confers striking sensitivity to phorbol ester toxicity, independent of growth stimulation.
  • This enhanced sensitivity is specific to biologically active phorbol esters.
  • Bryostatin, a related compound, did not elicit the same toxic response.

Conclusions:

  • Mutant Ras is a key determinant of sensitivity to phorbol ester-induced toxicity.
  • The findings provide a molecular basis for developing phorbol ester analogues as anticancer therapeutics.
  • This research clarifies the mechanism of phorbol ester toxicity in specific cellular contexts.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...